Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Microbiol Infect ; 20(11): 1183-8, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24930498

ABSTRACT

Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality worldwide. Increasing age has been associated with elevated circulating levels of pro-inflammatory mediators. We aimed to determine the impact of ageing on the systemic inflammatory response to CAP. In total 201 CAP patients were enrolled. Blood samples were obtained upon presentation, and on days 2, 3 and 5. For the current analysis patients≤50 and ≥80 years were included. The Pneumonia Severity Index (PSI) score was calculated at presentation. The study encompassed 46 CAP patients aged ≤50 years (median 37 years) and 41 CAP patients aged ≥80 years (median 84 years). In both groups Streptococcus pneumoniae was the common causative microorganism. Whereas most young patients had a PSI score of I (54%), 98% of elderly patients had a PSI score≥III (p<0.001). Four elderly patients died vs. none of the young patients (p 0.045). Older patients demonstrated lower serum C-reactive protein levels on admission and during the course of their hospitalization (p 0.001) in spite of more severe disease. Serum concentrations of pro-inflammatory (interleukin (IL)-6 and IL-8) and anti-inflammatory cytokines (IL-10 and IL-1 receptor antagonist) did not differ between age groups, although admission IL-8 levels tended to be higher in elderly patients (p 0.05). Cytokine levels were positively correlated with PSI in young but not in elderly patients. These results suggest that elderly patients show an absolute (C-reactive protein) or relative (cytokines) reduction in their systemic inflammatory response on admission for CAP.


Subject(s)
Community-Acquired Infections/complications , Community-Acquired Infections/pathology , Pneumonia, Pneumococcal/complications , Pneumonia, Pneumococcal/pathology , Systemic Inflammatory Response Syndrome/pathology , Adolescent , Adult , Age Factors , Aged, 80 and over , C-Reactive Protein/analysis , Cytokines/blood , Female , Humans , Male , Middle Aged , Prospective Studies , Severity of Illness Index , Survival Analysis , Young Adult
2.
Basic Res Cardiol ; 104(5): 511-22, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19255801

ABSTRACT

Cardiac sodium channels are responsible for conduction in the normal and diseased heart. We aimed to investigate regional and transmural distribution of sodium channel expression and function in the myocardium. Sodium channel Scn5a mRNA and Na(v)1.5 protein distribution was investigated in adult and embryonic mouse heart through immunohistochemistry and in situ hybridization. Functional sodium channel availability in subepicardial and subendocardial myocytes was assessed using patch-clamp technique. Adult and embryonic (ED14.5) mouse heart sections showed low expression of Na(v)1.5 in the HCN4-positive sinoatrial and atrioventricular nodes. In contrast, high expression levels of Na(v)1.5 were observed in the HCN4-positive and Cx43-negative AV or His bundle, bundle branches and Purkinje fibers. In both ventricles, a transmural gradient was observed, with a low Na(v)1.5 labeling intensity in the subepicardium as compared to the subendocardium. Similar Scn5a mRNA expression patterns were observed on in situ hybridization of embryonic and adult tissue. Maximal action potential upstroke velocity was significantly lower in subepicardial myocytes (mean +/- SEM 309 +/- 32 V/s; n = 14) compared to subendocardial myocytes (394 +/- 32 V/s; n = 11; P < 0.05), indicating decreased sodium channel availability in subepicardium compared to subendocardium. Scn5a and Na(v)1.5 show heterogeneous distribution patterns within the cardiac conduction system and across the ventricular wall. This differential distribution of the cardiac sodium channel may have profound consequences for conduction disease phenotypes and arrhythmogenesis in the setting of sodium channel disease.


Subject(s)
Heart Conduction System/metabolism , Muscle Proteins/metabolism , Myocardium/metabolism , Sodium Channels/metabolism , Action Potentials , Animals , Atrioventricular Node/metabolism , Bundle of His/metabolism , Cell Line , Gene Expression Regulation, Developmental , Heart Conduction System/embryology , Heart Ventricles/metabolism , Humans , Immunohistochemistry , In Situ Hybridization , Male , Mice , Muscle Proteins/genetics , NAV1.5 Voltage-Gated Sodium Channel , Patch-Clamp Techniques , Purkinje Fibers/metabolism , RNA, Messenger/metabolism , Recombinant Fusion Proteins/metabolism , Sodium Channels/genetics , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...